Template:Valvular heart disease: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 5: Line 5:
'''Valvular heart disease Microchapters'''
'''Valvular heart disease Microchapters'''
|- bgcolor="LightGrey"
|- bgcolor="LightGrey"
!
 


|- bgcolor="LightCoral"
|- bgcolor="LightCoral"
!
[[Valvular heart disease|Home]]
|-
!
|- bgcolor="Pink"
!
!
[[Valvular heart disease (patient information)|Patient Information]]
[[Valvular heart disease (patient information)|Patient Information]]
Line 19: Line 13:
!
!


|- bgcolor="Pink"
|- bgcolor="LightCoral"
!
!
[[Valvular heart disease overview|Overview]]
[[Aortic stenosis]]
|-  
|-  
!
!
Line 27: Line 21:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Valvular heart disease historical perspective|Historical Perspective]]
[[Aortic regurgitation]]
|-  
|-  
!
!
Line 33: Line 27:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Valvular heart disease classification|Classification]]
[[Mitral stenosis]]
|-  
|-  
!
!
Line 39: Line 33:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Valvular heart disease pathophysiology|Pathophysiology]]
[[Mitral regurgitation]]
|-  
|-  
!
!
Line 45: Line 39:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Valvular heart disease causes|Causes]]
[[Tricuspid stenosis]]
|-  
|-  
!
!
Line 51: Line 45:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Valvular heart disease differential diagnosis|Differentiating Valvular heart disease from other Diseases]]
[[Tricuspid regurgitation]]
|-  
|-  
!
!
Line 57: Line 51:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Valvular heart disease epidemiology and demographics|Epidemiology and Demographics]]
[[Pulmonary stenosis]]
|-  
|-  
!
!
Line 63: Line 57:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Valvular heart disease risk factors|Risk Factors]]
[[Pulmonary regurgitation]]
|-
!
 
|- bgcolor="Pink"
!
[[Valvular heart disease screening|Screening]]
|-
!
 
|- bgcolor="Pink"
!
[[Valvular heart disease natural history, complications and prognosis|Natural History, Complications and Prognosis]]
|-  
|-  
!
!
Line 81: Line 63:
|- bgcolor="CornFlowerBlue"
|- bgcolor="CornFlowerBlue"
!
!
Diagnosis
'''2014 AHA/ACC Guidelines for Management of Valvular Heart Disease'''
|-  
|-  
!
!


|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
[[Valvular heart disease history and symptoms|History and Symptoms]]
|-
!
!


|- bgcolor="LightSkyBlue"
!
[[Valvular heart disease physical examination|Physical Examination]]
|-  
|-  
!
!


|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
[[Valvular heart disease laboratory findings|Laboratory Findings]]
|-
!
!


|- bgcolor="LightSkyBlue"
!
[[Valvular heart disease electrocardiogram|Electrocardiogram]]
|-  
|-  
!
!


|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
[[Valvular heart disease chest x ray|Chest X Ray]]
|-
!
!


|- bgcolor="LightSkyBlue"
!
[[Valvular heart disease CT|CT]]
|-  
|-  
!
!
Line 123: Line 87:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Valvular heart disease MRI|MRI]]
|-
!
|- bgcolor="LightSkyBlue"
!
[[Valvular heart disease echocardiography or ultrasound|Echocardiography or Ultrasound]]
|-
!
|- bgcolor="LightSkyBlue"
!
[[Valvular heart disease other imaging findings|Other Imaging Findings]]
|-
!
|- bgcolor="LightSkyBlue"
!
[[Valvular heart disease other diagnostic studies|Other Diagnostic Studies]]
|-
!
|- bgcolor="LightSkyBlue"
!
[[Valvular heart disease cardiac catheterization|Cardiac Catheterization]]
|-
!
|- bgcolor="CadetBlue"
!
Treatment
|-
!
|- bgcolor="PaleTurquoise"
!
[[Valvular heart disease medical therapy|Medical Therapy]]
|-
!
|- bgcolor="PaleTurquoise"
!
[[Valvular heart disease surgery|Surgery]]
|-
!
|- bgcolor="PaleTurquoise"
!
[[Valvular heart disease primary prevention|Primary Prevention]]
|-
!
|- bgcolor="PaleTurquoise"
!
[[Valvular heart disease secondary prevention|Secondary Prevention]]
|-
!
|- bgcolor="PaleTurquoise"
!
[[Valvular heart disease cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
|-
!
|- bgcolor="PaleTurquoise"
!
[[Valvular heart disease future or investigational therapies|Future or Investigational Therapies]]
|-
!


|- bgcolor="CadetBlue"
!
Case Studies
|-  
|-  
!
!
|- bgcolor="PaleTurquoise"
!
[[Valvular heart disease case study one|Case #1]]
|-
!
|- bgcolor="PaleGoldenrod "
!
{{PAGENAME}} On the Web
|-
!
|- bgcolor="LightYellow"
!
[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=search&db=pubmed&term={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} Most recent articles]
|-
!
|- bgcolor="LightYellow"
!
[http://scholar.google.com/scholar?ie=UTF-8&oe=utf-8&q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&qt_s=Search&sa=N&tab=ps Most cited articles]
|-
!
|- bgcolor="LightYellow"
!
[http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=search&db=pubmed&term={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}%20AND%20systematic%5Bsb%5D  Review articles]
|-
!
|- bgcolor="LightYellow"
!
[http://www.google.com/search?hl=en&client=firefox-a&rls=org.mozilla:en-US:official&q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}+more:health_continuing_education&cx=disease_for_health_professionals&sa=N&oi=coopctx&resnum=0&ct=col3&cd=2 CME Programs]
|-
!
|- bgcolor="LightYellow"
!
[http://www.google.com/search?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}+ppt&ie=utf-8&oe=utf-8&aq=t&rls=org.mozilla:en-US:official&client=firefox-a Powerpoint slides]
|-
!
|- bgcolor="LightYellow"
!
[http://images.google.com/images?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&sa=N&tab=wi Images]
|-
!
|- bgcolor="LightYellow"
!
American Roentgen Ray Society Images of {{PAGENAME}}
:[http://goldminer.arrs.org/search.php?query={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} All Images]
:[http://goldminer.arrs.org/search.php?query={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}} X-ray}}}} X-rays]
:[http://goldminer.arrs.org/search.php?query={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}} Ultrasound}}}} Echo & Ultrasound]
:[http://goldminer.arrs.org/search.php?query={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}} CT}}}} CT Images]
:[http://goldminer.arrs.org/search.php?query={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}} MRI}}}} MRI]
|-
!
|- bgcolor="LightYellow"
!
[http://clinicaltrials.gov/search/open/condition={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} Ongoing Trials  at Clinical Trials.gov]
|-
!
|- bgcolor="LightYellow"
!
[http://www.guideline.gov/search/searchresults.aspx?Type=3&txtSearch={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&num=20 US National Guidelines Clearinghouse]
|-
!
|- bgcolor="LightYellow"
!
[http://www.nice.org.uk/search/guidancesearchresults.jsp?keywords={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&searchType=guidance NICE Guidance]
|-
!
|- bgcolor="LightYellow"
!
[http://google2.fda.gov/search?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&x=0&y=0&client=FDA&site=FDA&lr=&proxystylesheet=FDA&output=xml_no_dtd&getfields=* FDA on {{PAGENAME}}]
|-
!
|- bgcolor="LightYellow"
!
[http://www.cdc.gov/search.do?queryText={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&searchButton.x=33&searchButton.y=6&action=search CDC on {{PAGENAME}}]
|-
!
|- bgcolor="LightYellow"
!
[http://news.google.com/news?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&sa=N&tab=wn {{PAGENAME}} in the news]
|-
!
|- bgcolor="LightYellow"
!
[http://blogsearch.google.com/blogsearch?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&sa=N&tab=wb Blogs on {{PAGENAME}}]</small>
|-
!
|- bgcolor="LightYellow"
!
[http://maps.google.com/maps?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|map+top+hospital+Type page name here}}}}&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&ie=UTF-8&sa=N&hl=en&tab=wl Directions to Hospitals Treating Type page name here]
|-
!
|- bgcolor="LightYellow"
!
[http://www.google.com/search?hl=en&client=firefox-a&rls=org.mozilla%3Aen-US%3Aofficial&hs=QWo&q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}+AND+risk+score+OR+risk+calculator&btnG=Search Risk calculators and risk factors for {{PAGENAME}}]
|-
!


|}
|}

Revision as of 20:48, 6 December 2016